论文部分内容阅读
目的探究奥美拉唑联合铝碳酸镁和莫沙必利治疗胆汁反流性胃炎的临床疗效。方法选取北京丰台区铁营医院2013年1月—2015年12月收治的120例胆汁反流性胃炎患者,随机分成观察组、对照组,各60例。观察组通过奥美拉唑联合铝碳酸镁和莫沙必利治疗,对照组采取铝碳酸镁片和莫沙必利治疗,对比两组的临床效果及不良反应发生情况。结果观察组治疗总有效率(96.67%)明显高于对照组(83.33%),两组差异明显,P<0.05。治疗期间两组患者均无严重不良反应发生。结论胆汁反流性胃炎通过奥美拉唑联合铝碳酸镁和莫沙必利治疗,能够有效的提高临床疗效,同时未发生严重不良反应。
Objective To investigate the clinical efficacy of omeprazole combined with aluminum magnesium carbonate and mosapride in the treatment of bile reflux gastritis. Methods A total of 120 patients with bile reflux gastritis were enrolled from Tieying Hospital, Fengtai District, Beijing from January 2013 to December 2015, and randomly divided into observation group and control group, 60 cases each. The observation group was treated with omeprazole combined with aluminum magnesium carbonate and mosapride. The control group was treated with aluminum magnesium carbonate tablets and mosapride, and the clinical effects and adverse reactions of the two groups were compared. Results The total effective rate (96.67%) in the observation group was significantly higher than that in the control group (83.33%), with significant difference between the two groups (P <0.05). During the treatment of two groups of patients without serious adverse reactions. Conclusion Bile regurgitant gastritis through omeprazole combined with aluminum magnesium carbonate and mosapride, can effectively improve the clinical efficacy, and no serious adverse reactions.